The authors performed a detailed analysis of protein co-expression networks on a rigorously selected set of 10 lesions in five estrogen-receptor-positive/HER2-negative/Ki-67-positive luminal breast tumors. This evidence concerns the gene ESR1 and breast neoplasm.